Emily Mullin: We know, though, that with any drug, there are differences in response rates, but I think there's been such a spotlight on these anti-obesity drugs, because their results have been really hyped
The dual GIP/GLP-1 mechanism provides synergistic insulin secretion from pancreatic beta cells
Available strengths 1 For Research Use Only
Monitoring schedule When combining therapies, more frequent monitoring helps catch issues early: Month 1: Baseline labs including hormones (estradiol, progesterone, testosterone, FSH), metabolic panel, lipids, thyroid function, and HbA1c
It remains unclear whether Medicaid could eventually be used to expand GLP-1 coverage for weight loss